Salivary gland neoplasms in children

David Callender, R. A. Frankenthaler, M. A. Luna, Sook Lee Sang Sook Lee, H. Goepfert

Research output: Contribution to journalArticle

102 Citations (Scopus)

Abstract

Of 29 patients, aged 3 to 16 years, with nonvasoformative salivary gland tumors, 21 had malignant tumors. Mucoepidermoid carcinoma was the most common; adenocarcinoma, adenoid cystic carcinoma, and acinic cell carcinoma were equally represented. Pleomorphic adenoma was the exclusive benign lesion, occurring in eight patients. Mean follow-up for patients with malignant lesions was 13.6 years (minimum, 3.5 years). Absolute 2- and 5-year survival rates were 100% and 90%, respectively. Mean follow-up for benign lesions was 15.6 years; none recurred. Superficial or total parotidectomy is the treatment of choice for malignant parotid neoplasms. Benign parotid lesions are adequately controlled with parotidectomy based on extent of disease. Facial nerve sacrifice can often be avoided. We advocate postoperative radiotherapy for high-grade lesions or those with adverse prognostic factors, such as soft-tissue extension and perineural invasion.

Original languageEnglish (US)
Pages (from-to)472-476
Number of pages5
JournalArchives of Otolaryngology - Head and Neck Surgery
Volume118
Issue number5
StatePublished - 1992
Externally publishedYes

Fingerprint

Salivary Gland Neoplasms
Parotid Neoplasms
Acinar Cell Carcinoma
Mucoepidermoid Carcinoma
Pleomorphic Adenoma
Adenoid Cystic Carcinoma
Glandular and Epithelial Neoplasms
Facial Nerve
Adenocarcinoma
Radiotherapy
Survival Rate
Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Callender, D., Frankenthaler, R. A., Luna, M. A., Sang Sook Lee, S. L., & Goepfert, H. (1992). Salivary gland neoplasms in children. Archives of Otolaryngology - Head and Neck Surgery, 118(5), 472-476.

Salivary gland neoplasms in children. / Callender, David; Frankenthaler, R. A.; Luna, M. A.; Sang Sook Lee, Sook Lee; Goepfert, H.

In: Archives of Otolaryngology - Head and Neck Surgery, Vol. 118, No. 5, 1992, p. 472-476.

Research output: Contribution to journalArticle

Callender, D, Frankenthaler, RA, Luna, MA, Sang Sook Lee, SL & Goepfert, H 1992, 'Salivary gland neoplasms in children', Archives of Otolaryngology - Head and Neck Surgery, vol. 118, no. 5, pp. 472-476.
Callender D, Frankenthaler RA, Luna MA, Sang Sook Lee SL, Goepfert H. Salivary gland neoplasms in children. Archives of Otolaryngology - Head and Neck Surgery. 1992;118(5):472-476.
Callender, David ; Frankenthaler, R. A. ; Luna, M. A. ; Sang Sook Lee, Sook Lee ; Goepfert, H. / Salivary gland neoplasms in children. In: Archives of Otolaryngology - Head and Neck Surgery. 1992 ; Vol. 118, No. 5. pp. 472-476.
@article{b032bb2c09a748739db9502a79315fc0,
title = "Salivary gland neoplasms in children",
abstract = "Of 29 patients, aged 3 to 16 years, with nonvasoformative salivary gland tumors, 21 had malignant tumors. Mucoepidermoid carcinoma was the most common; adenocarcinoma, adenoid cystic carcinoma, and acinic cell carcinoma were equally represented. Pleomorphic adenoma was the exclusive benign lesion, occurring in eight patients. Mean follow-up for patients with malignant lesions was 13.6 years (minimum, 3.5 years). Absolute 2- and 5-year survival rates were 100{\%} and 90{\%}, respectively. Mean follow-up for benign lesions was 15.6 years; none recurred. Superficial or total parotidectomy is the treatment of choice for malignant parotid neoplasms. Benign parotid lesions are adequately controlled with parotidectomy based on extent of disease. Facial nerve sacrifice can often be avoided. We advocate postoperative radiotherapy for high-grade lesions or those with adverse prognostic factors, such as soft-tissue extension and perineural invasion.",
author = "David Callender and Frankenthaler, {R. A.} and Luna, {M. A.} and {Sang Sook Lee}, {Sook Lee} and H. Goepfert",
year = "1992",
language = "English (US)",
volume = "118",
pages = "472--476",
journal = "JAMA Otolaryngology - Head and Neck Surgery",
issn = "2168-6181",
publisher = "American Medical Association",
number = "5",

}

TY - JOUR

T1 - Salivary gland neoplasms in children

AU - Callender, David

AU - Frankenthaler, R. A.

AU - Luna, M. A.

AU - Sang Sook Lee, Sook Lee

AU - Goepfert, H.

PY - 1992

Y1 - 1992

N2 - Of 29 patients, aged 3 to 16 years, with nonvasoformative salivary gland tumors, 21 had malignant tumors. Mucoepidermoid carcinoma was the most common; adenocarcinoma, adenoid cystic carcinoma, and acinic cell carcinoma were equally represented. Pleomorphic adenoma was the exclusive benign lesion, occurring in eight patients. Mean follow-up for patients with malignant lesions was 13.6 years (minimum, 3.5 years). Absolute 2- and 5-year survival rates were 100% and 90%, respectively. Mean follow-up for benign lesions was 15.6 years; none recurred. Superficial or total parotidectomy is the treatment of choice for malignant parotid neoplasms. Benign parotid lesions are adequately controlled with parotidectomy based on extent of disease. Facial nerve sacrifice can often be avoided. We advocate postoperative radiotherapy for high-grade lesions or those with adverse prognostic factors, such as soft-tissue extension and perineural invasion.

AB - Of 29 patients, aged 3 to 16 years, with nonvasoformative salivary gland tumors, 21 had malignant tumors. Mucoepidermoid carcinoma was the most common; adenocarcinoma, adenoid cystic carcinoma, and acinic cell carcinoma were equally represented. Pleomorphic adenoma was the exclusive benign lesion, occurring in eight patients. Mean follow-up for patients with malignant lesions was 13.6 years (minimum, 3.5 years). Absolute 2- and 5-year survival rates were 100% and 90%, respectively. Mean follow-up for benign lesions was 15.6 years; none recurred. Superficial or total parotidectomy is the treatment of choice for malignant parotid neoplasms. Benign parotid lesions are adequately controlled with parotidectomy based on extent of disease. Facial nerve sacrifice can often be avoided. We advocate postoperative radiotherapy for high-grade lesions or those with adverse prognostic factors, such as soft-tissue extension and perineural invasion.

UR - http://www.scopus.com/inward/record.url?scp=0026735022&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026735022&partnerID=8YFLogxK

M3 - Article

C2 - 1315140

AN - SCOPUS:0026735022

VL - 118

SP - 472

EP - 476

JO - JAMA Otolaryngology - Head and Neck Surgery

JF - JAMA Otolaryngology - Head and Neck Surgery

SN - 2168-6181

IS - 5

ER -